Orchard Therapeutics plc (ORTX)

Jan 24, 2024 - ORTX was delisted (reason: acquired by Kyowa Kirin)

16.70

0.00 (0.00%)

Inactive · Last trade price on Jan 23, 2024

Orchard Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	2017 - 2018
Period Ending	Jan '24 Jan 23, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	2017 - 2018
Market Capitalization	-	48	166	422	1,327	1,351	Upgrade
Market Cap Growth	170.91%	-70.91%	-60.77%	-68.18%	-1.74%	-	Upgrade
Enterprise Value	-	-40	-28	279	986	1,532	Upgrade
PS Ratio	-	2.13	98.90	162.73	528.10	650.61	Upgrade
PB Ratio	-	0.49	0.79	2.37	4.44	4.34	Upgrade
P/TBV Ratio	-	0.51	0.81	2.41	4.44	4.34	Upgrade
EV/Sales Ratio	-	-	-	107.54	392.19	737.77	Upgrade
Debt / Equity Ratio	0.60	0.59	0.28	0.33	0.15	-	Upgrade
Asset Turnover	0.10	0.08	0.01	0.01	0.01	0.01	Upgrade
Inventory Turnover	17.73	36.62	64.66	-	-	-	Upgrade
Quick Ratio	2.88	2.66	6.00	4.17	6.19	7.28	Upgrade
Current Ratio	3.12	2.78	6.43	4.34	6.26	7.42	Upgrade
Return on Equity (ROE)	-71.50%	-97.76%	-74.45%	-63.64%	-53.53%	-115.90%	Upgrade
Return on Assets (ROA)	-29.23%	-28.94%	-28.89%	-26.41%	-28.23%	-63.41%	Upgrade
Return on Capital (ROIC)	-41.10%	-36.79%	-34.44%	-30.89%	-32.92%	-73.86%	Upgrade
Earnings Yield	-	-312.61%	-87.28%	-35.99%	-12.31%	-17.07%	Upgrade
FCF Yield	-	-171.18%	-76.93%	-32.90%	-12.85%	-7.52%	Upgrade
Buyback Yield / Dilution	-34.70%	-3.24%	-24.65%	-6.65%	-313.31%	-154.25%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q